Literature DB >> 8333776

Aerosol antibiotic treatment in cystic fibrosis.

J M Littlewood1, S W Smye, H Cunliffe.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1993        PMID： 8333776      PMCID： PMC1029378          DOI： 10.1136/adc.68.6.788

Source DB:  PubMed          Journal:  Arch Dis Child        ISSN： 0003-9888            Impact factor:   3.791


× No keyword cloud information.
  42 in total

1.  Efficacy of inhaled tobramycin in cystic fibrosis.

Authors:  C Semsarian
Journal:  J Paediatr Child Health       Date:  1990-04       Impact factor: 1.954

2.  Nebulized amphotericin B as prophylaxis against invasive aspergillosis in granulocytopenic patients.

Authors:  E Conneally; M T Cafferkey; P A Daly; C T Keane; S R McCann
Journal:  Bone Marrow Transplant       Date:  1990-06       Impact factor: 5.483

3.  Some factors influencing the efficiency of a jet nebuliser system.

Authors:  S W Smye; A Shaw; H M Norwood; J M Littlewood
Journal:  Clin Phys Physiol Meas       Date:  1990-05

4.  Why nebulise for more than five minutes?

Authors:  C O'Callaghan; A R Clark; A D Milner
Journal:  Arch Dis Child       Date:  1989-09       Impact factor: 3.791

5.  Aerosol carbenicillin and gentamicin treatment of Pseudomonas aeruginosa infection in patients with cystic fibrosis.

Authors:  M E Hodson; A R Penketh; J C Batten
Journal:  Lancet       Date:  1981-11-21       Impact factor: 79.321

6.  Aerosol chemotherapy in bronchopulmonary candidiasis.

Authors:  A Oehling; M Giron; M L Subira
Journal:  Respiration       Date:  1975       Impact factor: 3.580

Review 7.  Inhaled aerosols: lung deposition and clinical applications.

Authors:  S P Newman; J E Agnew; D Pavia; S W Clarke
Journal:  Clin Phys Physiol Meas       Date:  1982-02

8.  [On the problem of fungal superinfections of the respiratory organs and their treatment with inhalations and instillations of amphotericin B and pure Moronal].

Authors:  P Skobel
Journal:  Med Welt       Date:  1966-12-10

9.  Effects of various inhalation modes on the deposition of radioactive pressurized aerosols.

Authors:  S P Newman; D Pavia; N Garland; S W Clarke
Journal:  Eur J Respir Dis Suppl       Date:  1982

10.  The value of serum IgG titres against Pseudomonas aeruginosa in the management of early pseudomonal infection in cystic fibrosis.

Authors:  M M Brett; E J Simmonds; A T Ghoneim; J M Littlewood
Journal:  Arch Dis Child       Date:  1992-09       Impact factor: 3.791
View more
  7 in total

Review 1.  Ethical aspects of using radiolabelling in aerosol research.

Authors:  M L Everard
Journal:  Arch Dis Child       Date:  2003-08       Impact factor: 3.791

2.  Nebulised antibiotics for adults with cystic fibrosis.

Authors:  A K Webb; M E Dodd
Journal:  Thorax       Date:  1997-04       Impact factor: 9.139

3.  Diffuse panbronchiolitis and cystic fibrosis: East meets West.

Authors:  N Høiby
Journal:  Thorax       Date:  1994-06       Impact factor: 9.139

4.  Evaluation of two commercial jet nebulisers and three compressors for the nebulisation of antibiotics.

Authors:  J C Hung; G Hambleton; M Super
Journal:  Arch Dis Child       Date:  1994-10       Impact factor: 3.791

5.  Improvement of nebulised antibiotic delivery in cystic fibrosis.

Authors:  D Wilson; M Burniston; E Moya; A Parkin; S Smye; P Robinson; J Littlewood
Journal:  Arch Dis Child       Date:  1999-04       Impact factor: 3.791

6.  In vitro inhibition of neutrophil elastase activity by inhaled anti-Pseudomonas antibiotics used in cystic fibrosis patients.

Authors:  Andreas Hector; Matthias Kappler; Matthias Griese
Journal:  Mediators Inflamm       Date:  2010-06-16       Impact factor: 4.711

Review 7.  Ceftazidime. An update of its antibacterial activity, pharmacokinetic properties and therapeutic efficacy.

Authors:  C P Rains; H M Bryson; D H Peters
Journal:  Drugs       Date:  1995-04       Impact factor: 9.546
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.